|
 |
 |
|
| |
Contact data |
Full Professor
Department of Clinical Medicine
Via O. Rossi, 9 - 21100 Varese - Italy
Tel: +39 (0)332 217400/397400
Fax: +39 (0)332 217409/397409
E-mail: sergio.lecchini@uninsubria.it |
| |
Biography |
Born in Pisa, 15 October 1940, Degree in Medicine (University of Pisa)
From 1973, Research Assistant in Pharmacology, University of Pavia
From 1980, Associate Professor in Clinical Pharmacology
In the fields of basic and clinical pharmacology, his research interests
are focused mainly on neurotransmission in the autonomic nervous
system, neuroimmunopharmacology, immunopharmacology of central nervous
system drugs. As a visiting scientist, he has been at CNRS in Marseille
(France) and in the Department of Pharmacology in Aberdeen (Scotland)
where he has been working with Prof. H. Kosterlitz, dealing with
the mechanisms underlying the generation and spreading of excitation,
intrinsic neurons and neurotransmitter involved and neuroendocrine
mechanisms in the enteric nervous system. For many years, he has
taken part in studies concerning the adrenergic modulation of hematopoiesis
and the immune response. His laboratory has been among the first
research centers to deal with the presence and the role of catecholamines
in immune cells. Recent results concern physiopharmacology of human
leukocytes, with particular regard to functional modulation by neurotransmitters
and neuropeptides. He has published more than 90 papers on scientific
journals listed in Medline. |
| |
Research interests |
Main research interests
regard immunopharmacology, neuropharmacology, pharmacology of neuroimmunomodulation,
nervous system-immune system interactions (in particular adrenergic
and dopaminergic mechanisms and their clinical relevance in neurological
disorders, anti-tumor response, autoimmunity, immune tolerance).
Present studies are taking into account the physiopharmacology of
the intrinsic dopaminergic/adrenergic system of human lymphocytes
and its involvement in disease such as multiple sclerosis, Parkinson’s
disease, Alzheimer’s disease, Tourette’s syndrome, and
other neural and psychiatric disorders. Most recent results show how
naturally occurring regulatory T lymphocytes can be selectively modulated
through activation of dopaminergic receptors by both dopaminergic
agents, as well as from endogenous dopamine produced by regulatory
T lymphocytes themselves. The clinical relevance of these findings
is currently under evaluation in a number of fields including autoimmune
disease (multiple sclerosis, rheumatoid arthritis), neurodegenerative
disease, neoplasms. In view of the wide array of adrenergic and dopaminergic
agents currently in clinical use for various indications and of their
usually favourable therapeutic index, in-depth characterization of
these mechanisms could provide the rationale for further investigation
examining the therapeutic potential of such agents in a number of
major disease conditions. Scientific collaborations in this area include
the Laboratory for Experimental Pathology, Locarno CH (Head: Prof.
Georges J.M. Maestroni).
Immunopharmacology, with particular regard to the mechanisms regulating
spontaneous and acquired immune response in health and disease.
Recent
research in this field concern:
- the role of neurotransmitters and neuropeptides in the regulation
of human PMN function and the relevance of these mechanisms for the
immune effects of CNS drugs;
- the relationship between thyroid status and PMN function in humans;
- the contribution of the inflammatory mechanisms in cardiovascular
disease and in the effects of cardiovascular drugs (statins, drugs
acting on the renin-angiotensin system).
Other research interests include neuropharmacology and in particular
the pharmacology of the neurovegetative system. Interests in this
area regard the modulation of adrenergic and cholinergic neurotransmissione
in the autonomic nervous system by several receptor systems, and the
pharmacological analysis of signal transduction mechanisms involved.
A recently established research area regards the pharmacology of herbs
and herbal drugs, in the context of an International Collaborative
Network involving the University of Insubria (I), the University of
Heidelberg (D), the University of Zurich (CH), the Haute Ecole Valaisanne
(CH), the Alpine Institute for Phytopharmacology (CH).
Research projects are funded by both public and private institutions,
including:
- Italian Ministry of Instruction, University and Research;
- Regione Lombardia (UE PIC Interreg IIIA – 2000-2006);
- University of Insubria;
- National Multiple Sclerosis Society (www.nmss.org), New York, NY,
USA;
- Italian Foundation for Multiple Sclerosis (www.aism.it), Genua,
Italy. |
| |
Teaching experience
and appointments |
APPOINTMENTS
- Coordinator of the PhD Course in Clinical and Experimental Pharmacology,
University of Insubria;
- Director of the postgraduate School of specialization in Pharmacology,
School of Medicine, University of Insubria;
- Coordinator of the International Collaborative Network for the Pharmacotoxicological
Study of Medicinal Plants [involving the University of Insubria (I),
the University of Heidelberg (D), the University of Zurich (CH), the
Haute Ecole Valaisanne (CH), the Alpine Institute for Phytopharmacology
(CH)].
TEACHING
School of Medicine, University of Insubria:
- Pharmacology (I.C. Special pharmacology, 2nd Degree Course in Medicine
and Surgery);
- Neuropsychopharmacology (I.C. Special pharmacology, 2nd Degree Course
in Medicine and Surgery);
Courses of basic and clinical pharmacology are also given in postgraduate
medical Schools of specialization and in the Research Doctorate (PhD)
Course in Clinical and Experimental Pharmacology. |
| |
Representative
publications |
Martignoni E., Cosentino
M., Ferrari M., Porta G., Mattarucchi E., Marino F., Lecchini S.,
Nappi G. Two patients with COMT inhibitor-induced hepatic dysfunction
and UGT1A9 genetic polymorphism. Neurology 2005 (in press)
Marino F., Guasti L., Cosentino M., De Piazza D., Simoni C., Piantanida
E., Cimpanelli M., Klersy C., Bartalena L., Venco A., Lecchini S.
Thyroid hormone regulation of cell migration and oxidative metabolism
in polymorphonuclear leukocytes: clinical evidence in thyroidectomized
subjects on thyroxine replacement therapy. Life Sciences 2005 (in
press)
Marino F., Guasti L., Cosentino M., De Piazza D., Simoni C., Bianchi
V., Piantanida E., Cimpanelli M., Crespi C., Vanoli P., De Palma D.,
Klersy C., Frigo G., Bartalena L., Venco A., Lecchini S. Thyroid hormone
and thyrotropin regulate intracellular free calcium concentrations
in human polymorphonuclear leukocytes: in vivo and in vitro studies.
International Journal of Immunopathology and Pharmacology 2005 (in
press)
Cosentino M., Zaffaroni M., Ferrari M., Marino F., Bombelli R., Rasini
E., Frigo G., Ghezzi A., Comi G., Lecchini S. Interferon-b and interferon-g affect endogenous catecholamines in human peripheral blood mononuclear
cells: implications for multiple sclerosis. Journal of Neuroimmunology
2005, 162: 112-121.
Cosentino M., Martignoni E., Michielotto D., Calandrella D., Leoni
O., Riboldazzi G., Pacchetti C., Lecchini S., Nappi G., Frigo G. Medical
healthcare use in Parkinson’s disease: survey in a cohort of
ambulatory patients in Italy. BMC Health Services Research 2005, 5:
26 - doi:10.1186/1472-6963-5-26 (http://www.biomedcentral.com/1472-6963/5/26).
Trifirò G., Calogero G., Ippolito F.M., Cosentino M., Giuliani
R., Conforti A., Venegoni M., Mazzaglia G., Caputi A.P. Adverse drug
events in emergency department population: a prospective Italian study.
Pharmacoepidemiology and Drug Safety (Chichester, West Sussex) 2005,
14: 333-340.
Ferrari M., Cosentino M., Marino F., Bombelli R., Rasini E., Lecchini
S., Frigo G.M. Dopaminergic D1-like receptor-dependent inhibition
of tyrosine hydroxylase mRNA expression and catecholamine production
in human lymphocytes. Biochemical Pharmacology 2004, 67: 865-873.
Blandini F., Cosentino M., Mangiagalli A., Marino F., Samuele A.,
Rasini E., Fancellu R., Tassorelli C., Pacchetti C., Martignoni E.,
Riboldazzi G., Calandrella D., Lecchini S., Frigo G.M., Nappi G. Lymphocyte
levels of apoptosis-related proteins in patients with Parkinson’s
disease: effects of the dopaminergic treatment. Journal of Neural
Transmission 2004, 111: 1017-1030.
Cosentino M., Rasini E., Colombo C., Marino F., Blandini F., Ferrari
M., Samuele A., Lecchini S., Nappi G., Frigo G. Dopaminergic modulation
of oxidative stress and apoptosis in human peripheral blood lymphocytes:
evidence for a D1-like receptor-dependent protective effect. Free
Radical Biology & Medicine 2004, 36: 1233-1240.
Cosentino M., Zaffaroni M., Giorelli M., Marino F., Ferrari M., Bombelli
R., Rasini E., Trojano M., Lecchini S., Livrea P., Frigo G. Adrenergic
modulation of the immune response [peer-reviewed letter]. Trends in
Pharmacological Sciences 2004, 25: 350-351.
Marino F., Cosentino M., Ferrari M., Cattaneo S., Frigo G., Fietta
A.M., Lecchini S., Frigo G.M. Intracellular calcium changes induced
by the endozepine triakontatetraneuropeptide in human polymorphonuclear
leukocytes: role of protein kinase C and effect of calcium channel
blockers. BMC Cell Communication and Signaling 2004, 2: 6 - doi:10.1186/1478-811X-2-6
(http://www.biosignaling.com/content/2/1/6).
Marino F., Cosentino M., Fietta A.M., Cattaneo S., Frigo G., Ferrari
M., Lecchini S., Frigo G.M. Interleukin-8 production induced by the
endozepine triakontatetraneuropeptide in human neutrophils: role of
calcium and pharmacological investigation of signal transduction pathways.
Cellular Signalling 2003, 15: 511-517.
Cosentino M., Marino F., Bombelli R., Ferrari M., Lecchini S., Frigo
G.M. Unravelling dopamine (and catecholamine) physiopharmacology in
lymphocytes: open questions [peer-reviewed letter]. Trends in Immunology
2003, 24: 581-582.
Colombo C., Cosentino M., Marino F., Rasini E., Ossola M., Blandini
F., Mangiagalli A., Samuele A., Ferrari M., Bombelli R., Lecchini
S., Nappi G., Frigo G.M. Dopaminergic modulation of apoptosis in human
peripheral blood mononuclear cells: possible relevance for Parkinson's
disease. Annals of the New York Academy of Sciences 2003, 1010: 679-82.
Blandini F., Mangiagalli A., Cosentino M., Marino F., Samuele A.,
Rasini E., Fancellu R., Martignoni E., Riboldazzi G., Calandrella
D., Frigo G.M., Nappi G. Peripheral markers of apoptosis in Parkinson’s
disease: the effect of dopaminergic drugs. Annals of the New York
Academy of Sciences 2003, 1010: 675-78.
Leoni O., Martignoni E., Cosentino M., Michielotto D., Calandrella
D., Zangaglia R., Riboldazzi G., Oria C., Lecchini S., Nappi G., Frigo
G.M. Drug prescribing patterns in Parkinson’s disease: a pharmacoepidemiological
survey in a cohort of ambulatory patients. Pharmacoepidemiology and
Drug Safety (Chichester, West Sussex) 2002, 11: 149-157.
Cosentino M., Marino F., Bombelli R., Ferrari M., Rasini E., Lecchini
S., Frigo G.M. Stimulation with phytohaemagglutinin induces the synthesis
of catecholamines in human peripheral blood mononuclear cells: role
of protein kinase C and contribution of intracellular calcium. Journal
of Neuroimmunology 2002, 125: 125-133.
Reguzzoni M., Cosentino M., Rasini E., Marino F., Ferrari M., Bombelli
R., Congiu T., Protasoni M., Quacci D., Lecchini S., Raspanti M.,
Frigo G.M. Ultrastructural localization of tyrosine hydroxylase in
human peripheral blood mononuclear cells: effect of stimulation with
phytohaemagglutinin. Cell & Tissue Research 2002, 310: 297-304.
Cosentino M., Zaffaroni M., Marino F., Bombelli R., Ferrari M., Rasini
E., Lecchini S., Ghezzi A., Frigo G.M. Catecholamine production and
tyrosine hydroxylase expression in peripheral blood mononuclear cells
from multiple sclerosis patients: effect of cell stimulation and possible
relevance for activation-induced apoptosis. Journal of Neuroimmunology
2002, 133: 233-240.
Marino F., Cattaneo S., Cosentino M., Rasini E., Di Grazia L., Fietta
A.M., Lecchini S., Frigo G.M. Diazepam stimulates migration and phagocytosis
of human neutrophils: possible contribution of peripheral-type benzodiazepine
receptors and intracellular calcium. Pharmacology (Basel, Switzerland)
2001, 63: 42-49.
Cosentino M., Leoni O., Michielotto D., Punginelli M., Lecchini S.,
Frigo G.M. Increased reporting of adverse reactions to ACE inhibitors
associated with limitations to drug reimbursement for angiotensin
II receptor antagonists. European Journal of Clinical Pharmacology
2001, 57: 509-512.
Cosentino M., Marino F., Cattaneo S., Di Grazia L., Francioli C.,
Fietta A.M., Lecchini S., Frigo G.M. Diazepam-binding inhibitor-derived
peptides induce intracellular calcium changes and modulate human neutrophil
function. Journal of Leukocyte Biology 2000, 67: 637-643.
Cosentino M., Leoni O., Banfi F., Lecchini S., Frigo G.M. An approach
for the estimation of drug prescribing by use of the defined daily
dose methodology and drug dispensation data - theoretical considerations
and practical applications. European Journal of Clinical Pharmacology
2000, 56: 513-517.
Conti A., Maestroni G.J.M., Cosentino M., Frigo G.M., Lecchini S.,
Marino F., Bombelli R., Ferrari M., Brivio F., Roselli M.G., Lissoni
P. Evidencies for a neuroimmunomodulatory and a hematopoietic role
of the Luschka's coccygeal body. Neuroendocrinology Letters (Stockholm,
Sweden) 2000, 21: 391-403.
Cosentino M., Bombelli R., Ferrari M., Marino F., Rasini E., Maestroni
G.J.M., Conti A., Boveri M., Lecchini S., Frigo G.M. HPLC-ED measurement
of endogenous catecholamines in human immune cells and hematopoietic
cell lines. Life Sciences 2000, 68: 283-295.
Cosentino M., Marino F., Bombelli R., Ferrari M., Lecchini S., Frigo
G.M. Endogenous catecholamine synthesis, metabolism, storage and uptake
in human neutrophils. Life Sciences 1999, 64: 975-981.
Marino F., Cosentino M., Bombelli R., Ferrari M., Lecchini S., Frigo
G.M. Endogenous catecholamine synthesis, metabolism, storage and uptake
in human peripheral blood mononuclear cells. Experimental Hematology
1999, 27: 489-495.
Cosentino M., Leoni O., Oria C., Michielotto D., Massimo E., Lecchini
S., Frigo G.M. Hospital-based survey of doctors' attitudes to adverse
drug reactions and perception of drug-related risk for adverse reaction
occurrence. Pharmacoepidemiology and Drug Safety (Chichester, West
Sussex) 1999, 8: S27-S35.
Maestroni G.J.M., Cosentino M., Marino F., Togni M., Conti A., Lecchini
S., Frigo G.M. Neural and endogenous catecholamines in the bone marrow.
Circadian association of norepinephrine with percentage of cells in
G2/M. Experimental Hematology 1998, 26: 1172-1177.
Caldiroli E., Marino F., Cosentino M., De Ponti F., Fietta A.M., Taddei
M., Mazzone A., Gritti D., Tartara A., Zibetti A., Visintini D., Sasso
E., Lecchini S., Frigo G.M. Peripheral benzodiazepine receptor expression
on leukocytes and neutrophil function during chronic anticonvulsant
monotherapy. Pharmacology (Basel, Switzerland) 1998, 57: 215-221. |
| |
Clinical interests |
Clinical pharmacology (including:
applications of pharmacogenetics to individualization of drug therapies,
Therapeutic Drug Monitoring, and planning and evaluation of clinical
trials of drug therapies);
- Pharmacoepidemiology, with particular regard to the use of drugs
as indicators of incidence/prevalence of disease in populations and
to the pattern of drug prescriptions as indicators of quality/apppropriateness
of therapies;
- Pharmacovigilance, with emphasis on the methodologies for detection
and reporting of adverse drug reactions (ADR) in routine medical practice
and the factors affecting ADR reporting by medical practitioners.
|
|
|